Related Experiment Video
Updated: Jul 3, 2026

12:49
Detection of miRNA Targets in High-throughput Using the 3'LIFE Assay
Published on: May 25, 2015
let-7 microRNAs in development, stem cells and cancer
Ingo Büssing1, Frank J Slack, Helge Grosshans
1Friedrich Miescher Institute for Biomedical Research, Novartis Research Foundation, P.O. Box 2543, CH-4002 Basel, Switzerland.
Trends in Molecular Medicine
|August 5, 2008
Summary
MicroRNAs (miRNAs), like let-7, regulate cell differentiation and are conserved across species. Decreased let-7 expression is linked to increased cancer, suggesting it impacts stemness.
Area of Science:
- Molecular Biology
- Genetics
- Developmental Biology
Background:
- MicroRNAs (miRNAs) are small noncoding RNAs regulating gene expression.
- The let-7 miRNA family, discovered in C. elegans, is crucial for cell proliferation and differentiation.
- let-7 function is conserved in mammals, playing a role in development.
Purpose of the Study:
- To investigate the role of let-7 in regulating stemness.
- To explore the link between let-7 expression and tumorigenicity.
- To understand let-7's function in normal development and cancer.
Main Methods:
- Literature review and synthesis of existing research on let-7 and LIN28.
- Analysis of studies linking let-7 expression levels to patient prognosis.
- Comparative analysis of let-7 function in different organisms and contexts.
Main Results:
- Reduced let-7 expression correlates with increased tumor formation and poorer patient outcomes.
- LIN28, a pluripotency factor, can inhibit let-7 accumulation during normal development.
- let-7 acts as a tumor suppressor by inhibiting self-renewal and promoting differentiation.
Conclusions:
- let-7 plays a critical role in regulating stemness by balancing self-renewal and differentiation.
- Dysregulation of let-7 contributes to cancer development and progression.
- Understanding let-7's function may lead to novel cancer diagnostics and therapeutics.
More Related Videos
Related Concept Videos
MicroRNAs
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
MicroRNAs
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
MicroRNAs
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
Cancer Stem Cells and Tumor Maintenance
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer Stem Cells and Tumor Maintenance
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Induced Pluripotent Stem Cells
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...
Somatic cells are...

